Growth Hormone Therapy for Kids in San Francisco

Pediatric HGH Treatment and Telemedicine Growth Care Across the San Francisco Bay Area

Parents searching for growth hormone therapy for kids in San Francisco are often looking for answers because their child is growing more slowly than expected, falling behind on the growth chart, entering puberty later than peers, or projected to reach an adult height significantly below their expected family range.

For families throughout San Francisco, Daly City, South San Francisco, San Mateo, Burlingame, Millbrae, Pacifica, Redwood City, Palo Alto, Marin County, Oakland, Berkeley, and the greater San Francisco Bay Area, the most important first step is understanding why a child is not growing as expected.

Being short does not automatically mean a child needs human growth hormone (HGH).

A comprehensive pediatric growth evaluation may consider:

  • Current height and height percentile
  • Growth velocity
  • Changes in growth percentiles over time
  • Bone age and skeletal maturity
  • Pubertal development
  • Parental heights and family growth patterns
  • IGF-1 and other laboratory findings
  • Nutrition and overall health
  • Chronic medical conditions
  • Possible endocrine or genetic causes of slow growth

For children with an appropriate diagnosis and meaningful growth potential remaining, recombinant human growth hormone therapy may be one treatment option.[1,2]

The goal is not simply to make a child taller.

The goal is to determine why growth is slower than expected, how much growth potential remains, and whether treatment is medically appropriate before skeletal growth is complete.


Pediatric Growth Hormone Treatment in San Francisco

Families researching their child's height may search for:

  • Growth hormone therapy for kids San Francisco
  • HGH for children San Francisco
  • Pediatric growth hormone San Francisco
  • Growth hormone doctor San Francisco
  • Child height specialist San Francisco
  • Pediatric growth specialist San Francisco
  • Short stature treatment San Francisco
  • Growth hormone deficiency treatment San Francisco
  • Bone age evaluation San Francisco
  • Pediatric height evaluation Bay Area

Although these searches may begin with HGH, treatment should not be the first question.

The first question should be:

Why is this child growing slowly?

Some children are naturally short and completely healthy.

Others are late bloomers.

Some have constitutional growth delay, while others may have growth hormone deficiency, poor growth velocity, low IGF-1, delayed puberty, nutritional problems, or another medical condition affecting growth.

A detailed growth evaluation helps distinguish among these possibilities.


When Should Parents Be Concerned About Slow Growth?

One of the most important concepts for parents to understand is that height and growth are not the same thing.

A child can be short and still be growing normally.

Conversely, a child can currently be near average height but have an abnormal growth pattern if they are progressively falling through height percentiles.

This is why clinicians pay close attention to growth velocity.

Evaluation may be appropriate when a child:

  • Consistently grows more slowly than expected for age
  • Drops downward across height percentiles
  • Is significantly shorter than expected based on parental heights
  • Has delayed puberty
  • Has delayed skeletal maturation
  • Was born small for gestational age without adequate catch-up growth
  • Has persistent gastrointestinal, nutritional, or systemic symptoms
  • Has a predicted adult height significantly below the expected family range

For many school-age children before puberty, growth is approximately 2–2.5 inches per year. Persistent growth substantially below this range can be a reason for further evaluation, although normal growth velocity varies with age and pubertal stage.[2,3]


Understanding Growth Velocity

Growth velocity describes how quickly a child gains height over a specific period of time.

For example, imagine two children who are both at the 5th percentile for height.

Child A has remained near the 5th percentile for several years and continues growing steadily.

Child B was previously near the 40th percentile but has progressively fallen to the 5th percentile.

Those children may require very different evaluations.

The second child's downward crossing of percentiles can be more concerning than the final height percentile itself.

For this reason, previous pediatric growth charts can be extremely valuable during a growth evaluation.


What Is Human Growth Hormone?

Human growth hormone is naturally produced by the pituitary gland, a small endocrine gland located near the base of the brain.

Growth hormone is released in pulses rather than continuously.

One of its important actions is stimulating production of insulin-like growth factor-1 (IGF-1).

A simplified version of the growth pathway is:

Pituitary gland → Growth hormone → IGF-1 → Growth plates → Linear growth

Growth plates are specialized areas of cartilage located near the ends of long bones.

During childhood and adolescence, these areas allow bones to lengthen.

As puberty progresses, growth plates gradually mature and eventually fuse.

Once complete fusion has occurred:

Growth hormone cannot reopen the growth plates or meaningfully increase long-bone length.

This is one reason timing and skeletal maturity are important when evaluating a child or teenager for growth concerns.


What Is Growth Hormone Deficiency?

Growth hormone deficiency occurs when growth hormone production or secretion is insufficient to support normal childhood growth.

GHD is an important but relatively uncommon cause of pediatric growth failure.[1]

Children with growth hormone deficiency may demonstrate:

  • Poor growth velocity
  • Progressive loss of height percentile
  • Significant short stature
  • Delayed bone age
  • Delayed physical maturation
  • Low IGF-1 in some cases

However:

Short stature does not automatically mean growth hormone deficiency.

Many children who are shorter than average have normal GH production.

This is why diagnosis should incorporate the child's growth history, physical development, laboratory findings, skeletal maturity, and other clinical information rather than relying on a single test.[1,2]


Who May Be a Candidate for Growth Hormone Therapy?

Recombinant human growth hormone is used for several recognized pediatric growth conditions.

Potential candidates may include appropriately evaluated children with certain conditions such as:

Growth Hormone Deficiency

Children with confirmed GHD may experience significant improvement in growth velocity with appropriate recombinant GH replacement.[1,2]

Earlier treatment while substantial growth potential remains may allow more time for catch-up growth.


Idiopathic Short Stature

Some children with idiopathic short stature may be considered for GH therapy even though classic GHD has not been identified.

Response varies considerably.

The Pediatric Endocrine Society recommends individualized decision-making rather than automatically treating every child who meets a particular height threshold.[2]

Factors may include:

  • Degree of short stature
  • Growth velocity
  • Bone age
  • Puberty
  • Family height
  • Predicted adult height
  • Remaining growth potential
  • Expected benefit

Small for Gestational Age

Some children born small for gestational age do not experience adequate catch-up growth.

Selected children may be candidates for further evaluation and treatment.


Other Pediatric Growth Disorders

Growth hormone may also be used for specific pediatric conditions depending on the diagnosis and approved indication.

These can include certain genetic and developmental disorders.

Each condition has different:

  • Treatment goals
  • Expected responses
  • Dosing considerations
  • Monitoring requirements

Not Every Short Child Needs HGH

This distinction is especially important for families researching growth hormone online.

Short stature can occur without disease.

Familial Short Stature

Height is strongly influenced by genetics.

Shorter parents frequently have shorter children.

A child may remain at a lower percentile while still growing normally for their genetic potential.


Constitutional Growth Delay

Children with constitutional growth delay are often described as late bloomers.

They may:

  • Appear younger than classmates
  • Enter puberty later
  • Have delayed bone age
  • Experience their growth spurt later

Many ultimately reach an adult height consistent with their family's genetic pattern.


Delayed Puberty

Puberty timing can dramatically change how a child's growth pattern appears.

A teenager who has not yet entered the pubertal growth spurt may appear substantially shorter than classmates who began puberty earlier.

This does not automatically indicate GHD.

Evaluating puberty together with bone age and growth velocity can help provide a clearer picture.


Pediatric Growth Evaluation in San Francisco

Before discussing treatment, a pediatric growth evaluation should attempt to answer several questions:

How fast is the child growing?

Has the growth pattern changed?

Is skeletal development delayed?

How much growth remains?

Is there an identifiable reason for the slow growth?

The evaluation may include several components.


1. Growth Chart Review

Long-term growth charts can reveal whether a child:

  • Has always been short
  • Has remained on the same percentile
  • Recently slowed down
  • Is progressively crossing downward through percentiles

Several years of accurate measurements can be much more informative than one height measurement.


2. Growth Velocity

Growth velocity measures height gained over time.

Clinicians may compare measurements taken approximately 6–12 months apart to determine whether growth is occurring at an appropriate rate.

Growth velocity should be interpreted according to:

  • Age
  • Sex
  • Puberty
  • Previous growth pattern

3. Family Height

Parental heights provide useful information about genetic height potential.

A clinician may calculate midparental height and compare the child's projected adult height with the family's expected range.

A child who is short but projected to reach an appropriate family height may represent a very different situation from a child whose predicted height is far below genetic expectations.


4. Puberty Assessment

Puberty is one of the most important variables in adolescent growth.

Clinicians may assess whether puberty is:

  • Delayed
  • Appropriate for age
  • Rapidly progressing
  • Near completion

This becomes especially important when evaluating children around ages 12–16.

Chronological age alone cannot determine how much growth remains.


Bone Age X-Ray for Kids in San Francisco

A bone age X-ray is commonly used when evaluating pediatric growth concerns.

Typically, an X-ray of the left hand and wrist is compared with standardized references of skeletal development.

Bone age may provide information about:

  • Skeletal maturity
  • Remaining growth potential
  • Delayed development
  • Advanced development
  • Pubertal timing
  • Predicted adult height

Consider two boys who are both chronologically 14 years old.

One might have substantially delayed skeletal maturation and significant growth remaining.

Another might have a bone age approaching skeletal maturity with relatively little linear growth remaining.

Chronological age is the same.

Growth potential is not.


What Does Delayed Bone Age Mean?

Delayed bone age means skeletal development appears younger than chronological age.

This can sometimes indicate additional time for growth.

However:

Delayed bone age does not automatically mean a child needs growth hormone.

Possible causes include:

  • Constitutional growth delay
  • Growth hormone deficiency
  • Hypothyroidism
  • Nutritional problems
  • Chronic illness
  • Other endocrine disorders

Bone age should therefore be interpreted together with growth velocity, puberty, laboratory findings, and family growth history.


Laboratory Testing for Slow Growth

The laboratory evaluation varies according to the child's history and symptoms.

Testing may include:

  • IGF-1
  • IGFBP-3
  • TSH
  • Free T4
  • CBC
  • Comprehensive metabolic panel
  • Celiac screening
  • Inflammatory markers
  • Additional endocrine testing when clinically appropriate

The purpose is not simply to determine whether growth hormone is “high or low.”

It is to investigate why the child's growth pattern may be abnormal.


Does Low IGF-1 Mean Growth Hormone Deficiency?

No.

This is an important distinction.

IGF-1 provides useful information about the GH/IGF-1 pathway, but the result can be influenced by:

  • Age
  • Puberty
  • Nutritional status
  • Chronic illness
  • Other physiologic factors

The Pediatric Endocrine Society notes that IGF-1 can be low for reasons other than GHD and should be interpreted in the context of the child's overall clinical picture.[1]

Therefore:

Low IGF-1 ≠ automatic growth hormone deficiency diagnosis.

Further evaluation may be necessary.


Growth Hormone Stimulation Testing

Growth hormone is released in pulses.

As a result:

A random growth hormone blood level generally cannot reliably diagnose GHD.[1]

When significant concern remains after reviewing growth history, growth velocity, bone age, laboratory testing, and physical development, growth hormone stimulation testing may be considered.

During stimulation testing, medications are administered to provoke GH release, and blood samples are collected over several hours.

Even stimulation testing has limitations.

Results should be interpreted together with the child's complete growth pattern rather than in isolation.[1,2]


How Growth Hormone Therapy Works

When medically appropriate, recombinant human growth hormone is administered through subcutaneous injection.

Treatment schedules and products vary.

Children receiving GH therapy require ongoing monitoring to assess both effectiveness and safety.

Monitoring may include:

  • Height
  • Weight
  • Growth velocity
  • IGF-1
  • Pubertal development
  • Bone age when appropriate
  • Medication adherence
  • Side effects
  • Overall treatment response

Treatment should be individualized rather than based solely on age or body weight.[1,2]


How Quickly Does HGH Work in Children?

Families should think about growth hormone therapy in terms of months and years, not days or weeks.

Changes in growth velocity are generally evaluated over time.

For children who respond to therapy, improvement in growth rate may become measurable during the first several months.

The first year of treatment is often particularly informative because clinicians can compare the child's treatment growth velocity with their pretreatment growth rate.

Response varies according to:

  • Diagnosis
  • Age
  • Bone age
  • Puberty
  • Baseline growth velocity
  • GH dose
  • Adherence
  • Remaining growth potential

Regular measurements help determine whether treatment is producing a meaningful response.


How Much Taller Can HGH Make a Child?

No ethical provider can guarantee a specific number of inches.

Height response depends on multiple variables, including:

  • Diagnosis
  • Age at treatment initiation
  • Bone age
  • Pubertal stage
  • Baseline height
  • Pretreatment growth velocity
  • Genetics
  • Treatment duration
  • Adherence
  • Remaining growth potential

Children with true GHD may experience substantial catch-up growth when appropriately treated.[1,2]

Responses for other indications may be more variable.

The more useful question is:

“Given my child's diagnosis, skeletal maturity, and remaining growth potential, what outcome is realistic?”


Growth Hormone Therapy for Teenagers in San Francisco

Parents often become particularly concerned about height during adolescence.

A teenager may watch classmates suddenly grow several inches while their own height changes very little.

This does not necessarily mean something is wrong.

Puberty does not begin at exactly the same age for every child.

A teenager with:

  • Delayed puberty
  • Delayed bone age
  • Open growth plates
  • Significant remaining growth potential

may have a very different outlook from another teenager of the same chronological age with:

  • Advanced puberty
  • Near-mature bone age
  • Growth plates approaching fusion
  • Very little remaining growth velocity

For teenagers:

Bone age + puberty + growth velocity + diagnosis

often tell us much more than chronological age alone.


Is Age 14 Too Late for Growth Hormone?

Not necessarily.

Some 14-year-olds still have substantial growth remaining.

This is especially possible in children with later puberty or delayed skeletal maturation.

Other 14-year-olds may already be approaching final height.

Important questions include:

  • What is the bone age?
  • What stage of puberty has been reached?
  • What is the current growth velocity?
  • Are the growth plates still meaningfully active?
  • What is causing the slow growth?

Age alone cannot answer these questions.


Can HGH Work at Ages 15 or 16?

Possibly, but the remaining growth window becomes increasingly important.

Some teenagers have delayed bone age and open growth plates at these ages.

Others may be close to skeletal maturity.

The potential benefit of treatment generally becomes more limited as growth plate fusion approaches.

This is why a teenager should not be evaluated based solely on the number of birthdays they have had.

Skeletal maturity matters.


Can HGH Increase Height After Growth Plates Close?

No.

Once growth plates are completely fused, HGH cannot reopen them.

This makes timely evaluation important when persistent growth concerns exist.

However, this should not be interpreted as a reason to rush into treatment.

Early evaluation can be useful. Unnecessary treatment is not.

The diagnosis comes first.


Is Growth Hormone Therapy Safe for Children?

Recombinant human growth hormone has been used in pediatric medicine for decades.

When appropriately prescribed and monitored, it is generally well tolerated, although it is not risk-free.[1,2]

Potential issues clinicians may monitor for include:

  • Headaches
  • Intracranial hypertension
  • Slipped capital femoral epiphysis
  • Scoliosis progression during rapid growth
  • Glucose abnormalities
  • Thyroid dysfunction
  • Joint discomfort
  • Injection-site reactions

Medical history matters because certain conditions may require additional caution.

HGH should therefore be treated as prescription medical therapy, not as a general height-enhancement supplement.


Growth Hormone Therapy for Kids Across the San Francisco Bay Area

Families searching for pediatric growth hormone therapy in San Francisco may live throughout the surrounding Bay Area.

Communities may include:

  • San Francisco
  • Daly City
  • South San Francisco
  • Pacifica
  • San Bruno
  • Millbrae
  • Burlingame
  • San Mateo
  • Foster City
  • Belmont
  • San Carlos
  • Redwood City
  • Menlo Park
  • Palo Alto
  • Oakland
  • Berkeley
  • Alameda
  • Emeryville
  • Sausalito
  • Mill Valley
  • Tiburon
  • San Rafael
  • Corte Madera
  • Larkspur

Families throughout the San Francisco Peninsula, East Bay, Marin County, and greater Bay Area may seek evaluation when their child is not growing as expected.

Regardless of location, the medical questions remain the same:

How fast is the child growing?

Why is growth slow?

How much growth remains?

Is treatment medically appropriate?


Pediatric Growth Evaluation for San Francisco and the Peninsula

Families searching for a child height specialist in San Francisco, pediatric growth evaluation in San Mateo, or growth hormone therapy near Burlingame, Millbrae, Daly City, or South San Francisco should focus on understanding the child's complete growth pattern.

Important information includes:

  • Height percentile
  • Growth velocity
  • Bone age
  • Pubertal stage
  • Family height
  • Predicted adult height
  • Laboratory findings
  • Remaining growth potential

A comprehensive evaluation may result in treatment—or reassurance that medication is unnecessary.


Pediatric Growth Evaluation for Palo Alto, Redwood City and the Peninsula

Families from Redwood City, Menlo Park, Palo Alto, San Carlos, Belmont, Foster City, and surrounding Peninsula communities may seek evaluation when a child:

  • Is significantly shorter than expected
  • Has poor growth velocity
  • Is falling through percentiles
  • Has delayed puberty
  • Has delayed bone age
  • Has abnormal growth-related laboratory findings

Potential causes may include:

  • Constitutional growth delay
  • Familial short stature
  • Growth hormone deficiency
  • Thyroid dysfunction
  • Nutritional problems
  • Gastrointestinal disorders
  • Chronic disease
  • Genetic conditions

The objective is to determine the cause before selecting treatment.


Pediatric Growth Evaluation for Oakland, Berkeley and the East Bay

Families searching for pediatric growth care from Oakland, Berkeley, Alameda, Emeryville, and surrounding East Bay communities may have the same central concern:

Why isn't my child growing as expected?

Current height is only one part of the answer.

Combining:

Growth velocity + bone age + puberty + genetics + medical history + laboratory findings

provides a much more complete picture.


Pediatric Growth Evaluation for Marin County Families

Families from Sausalito, Mill Valley, Tiburon, Corte Madera, Larkspur, San Rafael, and surrounding Marin County communities may also seek specialized growth evaluation when a child is significantly shorter or developing later than peers.

Evaluation can help distinguish between:

  • Normal genetic short stature
  • Constitutional growth delay
  • Delayed puberty
  • Growth hormone deficiency
  • Other medical causes of slow growth

The appropriate treatment depends on the diagnosis.


What Parents Should Bring to a Growth Consultation

Parents can make a pediatric growth consultation more useful by gathering:

  • Previous growth charts
  • Heights from prior annual physicals
  • Recent laboratory results
  • Previous bone age reports
  • Bone age images when available
  • Birth weight
  • Birth length
  • Pregnancy and delivery history
  • Mother's height
  • Father's height
  • Family history of delayed puberty
  • Medication list
  • Relevant medical records

The more longitudinal information available, the easier it becomes to determine whether the child has always followed the same growth pattern or whether something has changed.


Questions to Ask Before Starting Growth Hormone Therapy

Parents considering HGH should understand:

  • Why is my child growing slowly?
  • What is my child's height percentile?
  • What is the current growth velocity?
  • Is my child dropping across percentiles?
  • What is the bone age?
  • Are the growth plates still open?
  • How much growth appears to remain?
  • What stage of puberty has been reached?
  • What is the predicted adult height?
  • How does projected height compare with family genetics?
  • Is there evidence of GHD?
  • Is HGH appropriate for this diagnosis?
  • What benefit can realistically be expected?
  • What are the risks?
  • How long might treatment continue?
  • What monitoring is required?
  • How will we determine whether treatment is working?
  • Would observation be reasonable?

The goal is to move beyond:

“Can HGH make my child taller?”

and answer the more important question:

“Why is my child growing slowly, and what is the most appropriate approach?”


Why Early Growth Evaluation Matters

Families are sometimes told:

“Just wait. They'll probably catch up.”

For many children, that may be appropriate.

But persistent poor growth can also be an early sign of:

  • Growth hormone deficiency
  • Thyroid dysfunction
  • Celiac disease
  • Nutritional problems
  • Delayed puberty
  • Chronic illness
  • Genetic growth disorders

A growth evaluation does not commit a family to medication.

It provides information.

Evaluation can help determine:

  • Whether growth is actually abnormal
  • Whether the child is a late bloomer
  • Whether skeletal maturation is delayed
  • Whether an underlying condition may be present
  • How much growth potential remains
  • Whether HGH may be appropriate
  • Whether continued observation is the better option

When an underlying growth disorder is present, identifying it before advanced skeletal maturation generally provides more opportunity to address the problem.


The Bottom Line

Families searching for growth hormone therapy for kids in San Francisco should begin with diagnosis—not medication.

Children can be short or grow slowly for many different reasons, including:

  • Family genetics
  • Constitutional growth delay
  • Delayed puberty
  • Growth hormone deficiency
  • Idiopathic short stature
  • Small for gestational age
  • Thyroid disease
  • Nutritional problems
  • Gastrointestinal disease
  • Chronic medical conditions
  • Genetic disorders

A comprehensive pediatric growth evaluation can help answer four important questions:

Why is the child growing slowly?

How much growth remains?

Are the growth plates still active?

Is HGH or another treatment medically appropriate?

For families throughout San Francisco, Daly City, South San Francisco, San Mateo, Burlingame, Millbrae, Pacifica, Redwood City, Palo Alto, Oakland, Berkeley, Marin County, and the greater Bay Area, the first step is understanding the child's individual growth pattern.

The goal is not simply greater height. The goal is healthy growth, accurate diagnosis, realistic expectations, and appropriate treatment while meaningful growth potential remains.


Schedule a Pediatric Growth Evaluation

If your child is:

  • Growing more slowly than expected
  • Falling on the growth chart
  • Experiencing delayed puberty
  • Significantly shorter than expected based on family height
  • Showing delayed bone age
  • Being evaluated for growth hormone deficiency

a comprehensive pediatric growth evaluation can provide greater clarity.

Families seeking growth hormone therapy for kids in San Francisco, a child height specialist in the Bay Area, or pediatric growth evaluation in Northern California can begin by reviewing:

  • Growth history
  • Growth velocity
  • Bone age
  • Pubertal development
  • IGF-1 and other laboratory testing when appropriate
  • Family height
  • Predicted adult height
  • Remaining growth potential

Contact HGHforChildren.com to schedule a pediatric growth evaluation and better understand what may be affecting your child's growth and whether treatment is medically appropriate.


Medically Reviewed By

Dr. Devin Stone, ND

Dr. Devin Stone, ND is a licensed naturopathic doctor and founder of HGHforChildren.com. His clinical focus includes pediatric growth evaluation, short stature assessment, delayed puberty, bone age analysis, growth hormone deficiency screening, IGF-1 interpretation, poor growth velocity, and individualized growth treatment planning for children and adolescents.

Through HGHforChildren.com, Dr. Stone educates families about childhood growth disorders, height prediction, growth velocity, skeletal maturity, growth hormone evaluation, and treatment options for children who may not be reaching their expected growth potential.


Medical References & Clinical Evidence

1. Pediatric Endocrine Society. Growth Hormone Deficiency: A Guide for Families. Pediatric Endocrine Society/American Academy of Pediatrics Section on Endocrinology Patient Education Committee.
Clinical resource discussing pediatric growth hormone deficiency, IGF-1, growth hormone stimulation testing, recombinant GH treatment, treatment duration, and growth plate considerations.

2. Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Hormone Research in Paediatrics. 2016;86(6):361–397. doi:10.1159/000452150.
Pediatric Endocrine Society clinical guideline addressing pediatric GHD, idiopathic short stature, GH treatment, treatment response, individualized decision-making, monitoring, risks, and benefits.

3. Barstow C, Rerucha C. Evaluation of Short and Tall Stature in Children. American Family Physician. 2015;92(1):43–50. PMID: 26132126.
Clinical review discussing growth velocity, growth charts, midparental height, bone age, short stature, normal growth variants, and indications for additional evaluation.

4. Pediatric Endocrine Society. Growth Hormone Injections: Useful Tips for Parents.
Patient education resource discussing recombinant growth hormone treatment, administration, monitoring, and treatment considerations.

Frequently Asked Questions

Frequently Asked Questions About Growth Hormone Therapy for Kids in San Francisco

Families throughout San Francisco and the Bay Area can seek specialized pediatric growth evaluation when a child has poor growth velocity, significant short stature, delayed puberty, abnormal bone age, or suspected growth hormone-related concerns. Treatment should follow an appropriate diagnostic evaluation.

Families seeking a child height specialist should look for a comprehensive growth evaluation that reviews longitudinal growth, bone age, puberty, family height, laboratory findings, and remaining growth potential rather than focusing solely on prescribing HGH.

No. Many short children are healthy and have normal growth hormone production. Growth velocity and the child's overall growth pattern are more informative than height alone.

Evaluation may include growth history, growth velocity, physical examination, bone age, IGF-1, IGFBP-3, and sometimes GH stimulation testing.[1,2]

Generally, no. Growth hormone is secreted in pulses, making a random GH measurement unreliable for diagnosing deficiency.[1]

No. IGF-1 can be influenced by age, puberty, nutrition, and other health factors. It should be interpreted together with the child's overall growth pattern.[1]

Not necessarily. Some 14-year-olds still have significant growth potential, particularly when puberty or bone age is delayed.

Potential benefit depends heavily on bone age, puberty, diagnosis, growth velocity, and whether meaningful growth plate activity remains.

No. Growth hormone cannot reopen completely fused growth plates.

There is no universal number. Response varies according to diagnosis, age, bone age, puberty, genetics, treatment duration, adherence, and remaining growth potential.

Treatment duration varies considerably. Some children receive therapy for several years depending on diagnosis, treatment response, puberty, and skeletal maturity.[1]

No. Delayed bone age may indicate additional growth time, but it can occur for many reasons and does not establish a need for growth hormone therapy.